Investigating Immune Escape by SARS-CoV-2 Variants

Completed

Conditions studied: COVID-19; Immunity

In brief

The purpose of this protocol is to investigate the ability of pre-existing immunity by natural infection or vaccination to prevent infections by emerging SARS-CoV-2 variants.

Key facts

Study ID

NCT05171803

Run by

University of California, Los Angeles

People needed

38

Starts

2021-05-29

Expected to finish

2023-10-15

Last updated by the study team

2023-11-08

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• People who have been fully vaccinated for COVID-19 2-12 weeks prior to enrollment or individuals <3 months post-COVID-19 infection.
• Collection of samples for blood samples will be done only from healthy, nonpregnant adults who weigh at least 110 pounds.
• Participants must be able to provide informed consent.

You may not qualify if…

• Subjects considered vulnerable including children, pregnant women, nursing home residents, or other institutionalized persons, fetuses, prisoners, and persons without decisional capacity.

Where it is running

• Curative — San Dimas, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.